Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DOTA-chelated lanthanide metal complexes are synthetic molecules where the macrocyclic ligand DOTA securely binds a trivalent lanthanide metal ion (such as gadolinium, lutetium, or yttrium). These highly stable chelates are widely employed as contrast agents in magnetic resonance imaging (MRI), as radiopharmaceuticals for targeted cancer imaging and therapy, and in experimental biosensing applications. The DOTA framework endows exceptional thermodynamic and kinetic stability to the complex, reducing metal ion release and associated toxicity risks. When conjugated to tumor-targeting moieties, DOTA-lanthanide complexes enable highly specific visualization or therapeutic delivery to disease sites. These are not conventional biomolecular targets, but engineered molecular entities designed for clinical diagnostics, therapy, and increasingly, advanced research applications.
DOTA chelates stabilize the lanthanide ion, enabling its use in imaging (paramagnetic for MRI, radioactive for PET/SPECT), and in targeted radiotherapy by directing cytotoxic radiation to specific tissues
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DOTA-chelated lanthanide metal complex.